跳至主要内容
临床试验/IRCT2015062322769N4
IRCT2015062322769N4已完成1 期

The assessment of the effect of L-carnitine supplementation versus placebo on serum total antioxidant and oxidant capacities, lipid profile in patients with pemphigus vulgaris

Vice chancellor for research, Tehran University of Medical Sciences0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 65 years(—)
性别
All

入选标准

  • INCLUSION CRITERIA: Willingness to cooperate; Affected by pemphigus vulgaris; Minimum one year of pemphigus vulgaris illness; Using Corticosteroid alone or with one of the Methotrexate, Azathioprine and Cellcept drugs; Age between 30 and 65 years old; BMI<35; Lack of Cardiovascular disease, renal, hepatic and inflammatory intestinal diseases; No alcohol consumption; Do not use of any antioxidant supplementation during the last 3 months; No consumption of Cisplatin, Theophylline and Valproate during the past month; Non-smoking and tobacco use (People who have smoked less than five cigarettes daily in previous 6 months); Lack of pregnancy and lactation
  • EXCLUSION CRITERIA: Changing the type of used drug; Find allergy symptoms at any time of the study

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tehran University of Medical Sciences

相似试验